Skip to main content
main-content

03-23-2018 | Oral combination medications | Article

SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Li D et al. Diabetes Obes Metab 2018; Advance online publication. doi: 10.1111/dom.13294

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.1111/dom.13294

Related topics